The 2026 Single-Cell Cancer Biology Gordon Research Conference (GRC) is a premier scientific forum titled "Deciphering the Multimodal and Spatial Drivers of Cancer." Scheduled for March 22–27, 2026, in Ventura, […]

The ANZGOG 2026 Annual Scientific Meeting is a flagship event of the Australian New Zealand Gynaecological Oncology Group (ANZGOG). The 2026 ASM, themed "On the Edge: Translating Innovation into Action," […]

The 2026 SITC Spring Scientific: Enhancing Cellular Therapies with Next-generation IO Molecules will be held from March 25–27, 2026, in a hybrid format with options to attend in Tucson, Arizona, […]

The 15th European Breast Cancer Conference (EBCC-15) is scheduled to take place from March 25–27, 2026, in Barcelona, Spain. As a premier international multidisciplinary platform established in 1998, the conference […]

The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen, Denmark, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as a key platform for advancing science, sharing education, and enhancing lung cancer care practices globally. With a comprehensive programme designed for medical oncologists, radiation oncologists, […]

The NCCN 2026 Nursing Program: Advancing Oncology Nursing is a specialized pre-conference event held on Thursday, March 26, 2026, at the Caribe Royale Orlando in Florida, with virtual attendance options […]

The NCCN 2026 Oncology Fellows Program: New Horizons in Quality Cancer Care™ is an in-person event held on Thursday, March 26, 2026, at the Caribe Royale Orlando in Florida. This program is specifically designed to meet the educational needs of second- and third-year medical, surgical, and radiation oncology fellows. The curriculum focuses on the practical […]

The ESTRO course on Stereotactic Radiotherapy and Radiosurgery for Brain Metastases and Skull Base Lesions will take place in Rome, Italy, from March 26–28, 2026. `Directed by Maximilian Niyazi, this course is designed to allow radiation oncologists, medical physicists, radiation therapists, and other specialists to deepen their expertise and master advanced SRS/SRT techniques specifically for treating […]

The 23rd Annual Meeting of the Japanese Society of Medical Oncology (JSMO2026) will take place from March 26–28, 2026, at PACIFICO Yokohama North and Exhibition Hall D in Yokohama, Japan. Centered on the theme “Medical Oncologists for Cancer Patients,” this year’s meeting marks the 20th anniversary of JSMO’s board certification program and offers a timely […]

The NCCN Annual Conference 2026 will be held from March 27–29, 2026, at the Caribe Royale Orlando in Florida, with virtual attendance options also available. This conference brings together oncology leaders to share cutting-edge cancer research and provide actionable strategies to improve patient outcomes through evidence-based, expert consensus-driven NCCN Clinical Practice Guidelines in Oncology (NCCN […]

The NECTA Drug Development Meeting 2026 will be held on Friday, 27 March 2026, at the Garvan Institute of Medical Research in Sydney. This specialized forum focuses on critical shifts in early-phase oncology, including the reformation of dose optimization and the challenges of agnostic precision oncology for unknown targets. The agenda also highlights novel clinical […]

The Summit on Cancer Health Disparities (SCHD26) is a two-day conference organized by Binaytara, scheduled for March 27–28, 2026, at the Hyatt Regency Bellevue in Bellevue, Washington, United States. This summit is dedicated to addressing the critical issue of cancer health disparities. Attendees can earn up to 12.75 credits, and the conference is designed to […]

The 13th Belgian Multidisciplinary meeting on Urological Cancers (BMUC 2026) is a specialized oncology congress scheduled for Friday, March 27, and Saturday, March 28, 2026. Organized by the Belgian Multidisciplinary Urology Group, the meeting serves as a key platform for urologists, medical oncologists, and radiation oncologists to discuss the latest multidisciplinary management strategies for urological […]

The ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing is an intensive educational symposium scheduled for March 27–28, 2026, in Beijing, China. Co-chaired by Giuseppe Curigliano and Binghe Xu, this 1.5-day course is specifically designed for experienced oncologists and oncology […]